Smoking cessation correlates with a reduction in the risk of cataract extraction, although the risk persists for more than 20 years.
High quality communication in tobacco treatment programs with lung cancer screenings was significantly associated with self-efficacy for smoking cessation.
Issues related to rheumatoid arthritis (RA), such as distraction from pain and frustration of living with RA, may impede smoking cessation in RA patients.
A smoking cessation intervention offered in a preadmission clinic is associated with decreased rates of smoking on the day of surgery and 30 days postoperatively.
Adults with mental illness have a smoking rate that is 70% higher than adults with no mental illness and die approximately 25 years earlier than the general population, due largely to their high rates of substance use—including cigarette smoking.
Even if you take into account the weight gain that usually follows, quitting smoking still reduces the risk of cardiovascular disease in people without diabetes, according to a new study.
Smoking cessation is associated with improved survival for patients who undergo percutaneous coronary intervention (PCI).
A study in The Lancet Respiratory Medicine suggests that the rate at which smokers metabolize nicotine could be a significant factor in guiding smoking cessation treatment.
Results from a placebo-controlled study evaluating Chantix (varenicline; Pfizer) in pediatric patients 12-16 years of age showed that the smoking cessation treatment was not associated with a significant increase in abstinence rates in this patient population.
Smokers with certain high-risk genetic variants find it more difficult to quit smoking but are more likely to respond to cessation pharmacotherapy.